Nct01207440 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nct01207440. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nct01207440 Today - Breaking & Trending Today

Early Cytogenetic or Molecular Landmark Response to Ponatinib Predicts Outcomes in CP-CML

Early cytogenetic and molecular responses achieved with ponatinib was significantly linked with better long-term progression-free survival and overall survival in patients with highly resistant, pretreated chronic-phase chronic myeloid leukemia. ....

United States , Hagopm Kantarjian , Department Of Leukemia , University Of Texas Md Anderson Cancer Center , Samsung Distinguished Leukemia Chair , Cancer Medicine , Society Of Hematologic Oncology Annual Meeting Soho , Hematologic Oncology , Precision Medicine In Oncology , 2023 Soho Annual Meeting , Chronic Myeloid Leukemia ,